Literature DB >> 1610855

Lymphocytic subsets and histopathologic changes associated with the development of heart transplant arteriosclerosis.

D V Cramer1, G D Wu, F A Chapman, E Cajulis, H K Wang, L Makowka.   

Abstract

Transplantation of vascularized organ allografts is associated with the development of arteriosclerosis in the vessels of the donor graft. We have recently examined the distribution of lymphocytic/mononuclear inflammatory cell subsets and histopathologic changes seen in the sequential development of transplant arteriosclerosis in cardiac allografts exchanged between inbred rat strain combinations (LEW-to-F344) that differ for weak histocompatibility loci. The donor grafts were harvested at 7, 14, 21, 28, 50 to 65, and 90 days after transplantation, and the vascular lesions were characterized for the immunopathologic changes associated with the chronic rejection of the grafts. The inflammatory cell infiltration of the graft myocardium was present as early as 7 days after transplantation (53.37 +/- 9.06 inflammatory cells/high-power field), and the accumulation of cells increased at 3 and 4 weeks after transplantation (112.12 +/- 16.58 and 130.40 +/- 21.24 cells/high-power field, respectively). The infiltrating inflammatory cells in the grafts at 4 weeks after transplantation were predominantly ED-1+ macrophages (63.39%), with a substantial number of OX19+ T lymphocytes (28%), OX8+ Tc/s cells (25.4%), 3.2.3+ natural killer cells (16.89%), W3/25+ Th cells (20.2%), and a small number of OX33+ B lymphocytes (1.13%) and interleukin-2 receptor+ T lymphocytes (2.6%). Among the T-cell population, most (87.6%) were positive (R73+) for T-cell receptors. The arteriosclerotic lesions present in the cardiac grafts exhibited a gradual increase in severity of the vascular intimal proliferation and a similar pattern of increased intensity of cellular infiltration. The lesions were infiltrated with inflammatory cells beginning in the first week and increasing for the first month after transplantation.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1992        PMID: 1610855

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  11 in total

1.  Fibronectin-mononuclear cell interactions regulate type 1 helper T cell cytokine network in tolerant transplant recipients.

Authors:  A J Coito; K Onodera; H Kato; R W Busuttil; J W Kupiec-Weglinski
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

2.  FK 506 inhibits the development of transplant arteriosclerosis.

Authors:  G D Wu; D V Cramer; F A Chapman; E Cajulis; H K Wang; T E Starzl; L Makowka
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

3.  Chronic cardiac rejection: identification of five upregulated genes in transplanted hearts by differential mRNA display.

Authors:  U Utans; P Liang; L R Wyner; M J Karnovsky; M E Russell
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-05       Impact factor: 11.205

4.  Donor and recipient leukocytes in organ allografts of recipients with variable donor-specific tolerance: with particular reference to chronic rejection.

Authors:  N Ichikawa; A J Demetris; T E Starzl; Q Ye; T Okuda; H J Chun; K Liu; Y M Kim; N Murase
Journal:  Liver Transpl       Date:  2000-11       Impact factor: 5.799

5.  Donor MHC and adhesion molecules in transplant arteriosclerosis.

Authors:  C Shi; M W Feinberg; D Zhang; A Patel; C U Sim; Z M Dong; S M Chapman; J C Gutierrez-Ramos; D D Wagner; N E Sibinga; E Haber
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

6.  Identification and upregulation of galactose/N-acetylgalactosamine macrophage lectin in rat cardiac allografts with arteriosclerosis.

Authors:  M E Russell; U Utans; A F Wallace; P Liang; R J Arceci; M J Karnovsky; L R Wyner; Y Yamashita; C Tarn
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

7.  Cloning and characterization of allograft inflammatory factor-1: a novel macrophage factor identified in rat cardiac allografts with chronic rejection.

Authors:  U Utans; R J Arceci; Y Yamashita; M E Russell
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

8.  Chronic cardiac rejection in the LEW to F344 rat model. Blockade of CD28-B7 costimulation by CTLA4Ig modulates T cell and macrophage activation and attenuates arteriosclerosis.

Authors:  M E Russell; W W Hancock; E Akalin; A F Wallace; T Glysing-Jensen; T A Willett; M H Sayegh
Journal:  J Clin Invest       Date:  1996-02-01       Impact factor: 14.808

9.  Immunologic basis of transplant-associated arteriosclerosis.

Authors:  C Shi; W S Lee; Q He; D Zhang; D L Fletcher; J B Newell; E Haber
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

10.  Coronary atherosclerosis in transplanted mouse hearts. I. Time course and immunogenetic and immunopathological considerations.

Authors:  P S Russell; C M Chase; H J Winn; R B Colvin
Journal:  Am J Pathol       Date:  1994-02       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.